Neovacs SA(FR:ALNEV)
€0.08+0.00 (+4.11%)
FR:ALNEV
Neovacs SA Revenue
€0.08
At close:+0.00 (+4.11%)
Want to see FR:ALNEV full AI Analyst Report?
Neovacs SA (ALNEV) Revenue
5 Followers
Neovacs SA Revenue
Neovacs SA had a revenue of 71.05K in the quarter ending Dec 31, 2025, with -54.96%. This bring the company's revenue in the last twelve months to 228.77K, Increased 15.09%. In the fiscal year ending Dec 31, 2025, Neovacs SA had annual revenue of 161.78K with -55.84% growth.
- Revenue (ttm)
- 228.77K
- Revenue Growth
- -44.46%
- P/S Ratio
- 0.82
- Revenue/Employee
- EUR 10,111
- Employees
- 16
- Market Cap
- EUR 132.98K
Revenue Chart
Neovacs SA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 161.78K | -204.57K | -55.84% |
| Dec 31, 2023 | 366.35K | -167.07K | -31.32% |
| Dec 31, 2023 | 533.41K | 532.30K | 47868.71% |
| Dec 31, 2022 | 1.11K | -21.48K | -95.08% |
| Dec 31, 2021 | 22.59K | -7.19K | -24.14% |
| Dec 31, 2020 | 29.78K | 29.78K | ― |
| Dec 31, 2019 | 0.00 | -145.00K | -100.00% |
| Dec 31, 2018 | 145.00K | 145.00K | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.